Australia markets close in 1 hour 57 minutes

Actinogen Medical Limited (ACW.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1100+0.0050 (+4.76%)
As of 01:53PM AEDT. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 215.69M
Enterprise value 199.48M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.92
Enterprise value/revenue N/A
Enterprise value/EBITDA -21.97

Trading information

Stock price history

Beta (5Y monthly) 2.45
52-week change 3-16.00%
S&P500 52-week change 3-12.31%
52-week high 30.1800
52-week low 30.0400
50-day moving average 30.1095
200-day moving average 30.0838

Share statistics

Avg vol (3-month) 31.93M
Avg vol (10-day) 3917.04k
Shares outstanding 51.8B
Implied shares outstanding 6N/A
Float 81.26B
% held by insiders 119.78%
% held by institutions 115.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 303 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin -260.91%
Operating margin (ttm)-261.90%

Management effectiveness

Return on assets (ttm)-28.59%
Return on equity (ttm)-48.46%

Income statement

Revenue (ttm)3.64M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)88.20%
Gross profit (ttm)3.64M
EBITDA -9.21M
Net income avi to common (ttm)-9.5M
Diluted EPS (ttm)-0.0050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.37M
Total cash per share (mrq)0.01
Total debt (mrq)165.27k
Total debt/equity (mrq)0.76
Current ratio (mrq)13.80
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-9.52M
Levered free cash flow (ttm)-5.98M